ArticleFrontiers in microbiology2025
Genistein supplementation modulates the intestinal microbiota-liver-lumbar muscle metabolic axis in DLY commercial pigs without concomitant changes in growth performance.
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genistein is widely found in leguminous plants. As an isoflavone, it has functions similar to mammalian estrogen and has effects on many aspects such as animal carcass performance, intestinal flora composition and physiological metabolism. This study aimed to investigate the effects of genistein supplementation on the carcass performance of commercial pigs via intestinal microorganisms, liver and lumbar muscle metabolites. Sixteen DLY commercial pigs were divided into two groups: a fed group receiving a diet supplemented with 160 mg/kg genistein and a control group without supplementation; the intervention lasted about 74 days. The bacterial genome of the 16SrRNA V3-V4 region was sequenced to observe the diversity and composition changes of microorganisms in the feces of the fed group and the control group. At the same time, the differential metabolites and metabolic pathways of the liver and lumbar muscle tissues of the fed group and the control group were jointly analyzed. The results of the study showed that the addition of genistein to feed can increase the relative abundance of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.